<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.cmjournal.org/feeds/latestarticles/journal?quantity=&amp;format=rss&amp;version=">
        <title>Chinese Medicine - Latest Articles</title>
        <link>http://www.cmjournal.org</link>
        <description>The latest research articles published by Chinese Medicine</description>
        <dc:date>2009-07-02T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.cmjournal.org/content/4/1/13" />
                                <rdf:li rdf:resource="http://www.cmjournal.org/content/4/1/12" />
                                <rdf:li rdf:resource="http://www.cmjournal.org/content/4/1/11" />
                                <rdf:li rdf:resource="http://www.cmjournal.org/content/4/1/10" />
                                <rdf:li rdf:resource="http://www.cmjournal.org/content/4/1/9" />
                                <rdf:li rdf:resource="http://www.cmjournal.org/content/4/1/8" />
                                <rdf:li rdf:resource="http://www.cmjournal.org/content/4/1/7" />
                                <rdf:li rdf:resource="http://www.cmjournal.org/content/4/1/6" />
                                <rdf:li rdf:resource="http://www.cmjournal.org/content/4/1/5" />
                                <rdf:li rdf:resource="http://www.cmjournal.org/content/4/1/4" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.cmjournal.org/content/4/1/13">
        <title>Effects of triptolide from Radix Tripterygium wilfordii (Leigongteng) on cartilage cytokines and transcription factor NF-kappaB: a study on induced arthritis in rats</title>
        <description>Background Triptolide, an active compound of Radix Tripterygium wilfordii, is immunosuppressive, cartilage protective and anti-inflammatory both in human and animal studies of various inflammatory and autoimmune diseases, including rheumatoid arthritis, but its therapeutic mechanism remains unclear. The aim of this study is to investigate the effects of triptolide on cartilage cytokines in the CIA model. Methods Sprague Dawley rats were immunized with type II collagen and orally administered with triptolide. The arthritic scores and incidence changes of the rats were observed. The expression of TNF-alpha, IL-6, COX-2 and NF-kappaB in paw cartilage was studied with immunohistochemical staining. Results Triptolide, at both high and low doses, significantly lowered the arthritic scores, delayed the onset of arthritis and lowered the arthritis incidence. Triptolide treatment at both high and low doses lowered the expression of TNF-alpha, IL-6, COX-2 and NF-kappaB in paw cartilage in arthritic rats. Conclusion Triptolide lowers the arthritic scores, delays the onset of collagen induced arthritis and reduces the expressions of TNF-alpha, IL-6, NF-kappaB and COX-2 in paw cartilage in arthritic rats.</description>
        <link>http://www.cmjournal.org/content/4/1/13</link>
                <dc:creator>Cheng Xiao</dc:creator>
                <dc:creator>Jing Zhou</dc:creator>
                <dc:creator>Yinghui He</dc:creator>
                <dc:creator>Hongwei Jia</dc:creator>
                <dc:creator>Linhua Zhao</dc:creator>
                <dc:creator>Ning Zhao</dc:creator>
                <dc:creator>Aiping Lu</dc:creator>
                <dc:source>Chinese Medicine 2009, 4:13</dc:source>
        <dc:date>2009-07-02T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8546-4-13</dc:identifier>
        <prism:publicationName>Chinese Medicine</prism:publicationName>
        <prism:issn>1749-8546</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>13</prism:startingPage>
        <prism:publicationDate>2009-07-02T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cmjournal.org/content/4/1/12">
        <title>Effect of Fuzheng Huayu formula and its actions against liver fibrosis</title>
        <description>Liver fibrosis is a common histological process to develop into cirrhosis in various chronic liver diseases including chronic hepatitis and fatty liver. Therefore anti-liver fibrosis is very important strategy to treat chronic liver diseases. Fuzheng Huayu (FZHY), a preparation containing herbs such as Radix Salvia Miltiorrhizae, Cordyceps, Semen Persicae, was formulated on the basis of Chinese medicine theory in treating liver fibrosis and was approved. Pharmacological studies and clinical trials demonstrate that FZHY has a significant effect against liver fibrosis and that many of the pharmacological actions are attributable to the effect. This article reviews the effects and actions of FZHY, in particular the effects observed from clinical trials in treating liver fibrosis caused by chronic hepatitis B and the actions on inhibition of hepatic stellate cell activation, protection of hepatocytes and inhibition of hepatic sinusoidal capillarization. This article also reviews the coordinated effects of the constituent herbs of FZHY and the actions of their active compounds such as salvianonic acid B (SA-B) on liver fibrosis.</description>
        <link>http://www.cmjournal.org/content/4/1/12</link>
                <dc:creator>Chenghai Liu</dc:creator>
                <dc:creator>Yiyang Hu</dc:creator>
                <dc:creator>Lieming Xu</dc:creator>
                <dc:creator>Cheng Liu</dc:creator>
                <dc:creator>Ping Liu</dc:creator>
                <dc:source>Chinese Medicine 2009, 4:12</dc:source>
        <dc:date>2009-06-29T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8546-4-12</dc:identifier>
        <prism:publicationName>Chinese Medicine</prism:publicationName>
        <prism:issn>1749-8546</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>12</prism:startingPage>
        <prism:publicationDate>2009-06-29T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cmjournal.org/content/4/1/11">
        <title>Hypoglycemic herbs and their action mechanisms</title>
        <description>Conventional drugs treat diabetes by improving insulin sensitivity, increasing insulin production and/or decreasing the amount of glucose in blood. Several herbal preparations are used to treat diabetes, but their reported hypoglycemic effects are complex or even paradoxical in some cases. This article reviews recent findings about some of the most popular hypoglycemic herbs, such as ginseng, bitter melon and Coptis chinensis. Several popular commercially available herbal preparations are also discussed, including ADHF (anti-diabetes herbal formulation), Jiangtangkeli, YGD (Yerbe Mate-Guarana-Damiana) and BN (Byakko-ka-ninjin-to). The efficacy of hypoglycemic herbs is achieved by increasing insulin secretion, enhancing glucose uptake by adipose and muscle tissues, inhibiting glucose absorption from intestine and inhibiting glucose production from heptocytes.</description>
        <link>http://www.cmjournal.org/content/4/1/11</link>
                <dc:creator>Hongxiang Hui</dc:creator>
                <dc:creator>George Tang</dc:creator>
                <dc:creator>Vay Liang Go</dc:creator>
                <dc:source>Chinese Medicine 2009, 4:11</dc:source>
        <dc:date>2009-06-12T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8546-4-11</dc:identifier>
        <prism:publicationName>Chinese Medicine</prism:publicationName>
        <prism:issn>1749-8546</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>11</prism:startingPage>
        <prism:publicationDate>2009-06-12T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cmjournal.org/content/4/1/10">
        <title>Probing the mystery of Chinese medicine meridian channels with special emphasis on the connective tissue interstitial fluid system, mechanotransduction, cells durotaxis and mast cell degranulation</title>
        <description>This article hypothesizes that the Chinese medicine meridian system is a special channel network comprising of skin with abundant nerves and nociceptive receptors of various types, and deeper connective tissues inside the body with the flowing interstitial fluid system. These meridian channels provide efficient migratory tracks mainly due to durotaxis (also including chemotaxis) for mast cells, fibroblasts and other cells to migrate and carry out a number of physiological functions. Acupuncture acting on meridian channel causes cytoskeletal remodeling through mechanotransduction, leading to regulation of gene expression and the subsequent production of related proteins. Also, stimulation on cell surface can trigger Ca2+ activities, resulting in a cascade of intra- and inter-cellular signaling. Moreover, nerve endings in the meridian channels interact with mast cells and induce the degranulation of these cells, leading to the release of many specific biomolecules needed for homeostasis, immune surveillance, wound healing and tissue repair. Acupoint along a meridian channel is a functional site to trigger the above functions with specificity and high efficiency.</description>
        <link>http://www.cmjournal.org/content/4/1/10</link>
                <dc:creator>Peter Chin Wan Fung</dc:creator>
                <dc:source>Chinese Medicine 2009, 4:10</dc:source>
        <dc:date>2009-05-29T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8546-4-10</dc:identifier>
        <prism:publicationName>Chinese Medicine</prism:publicationName>
        <prism:issn>1749-8546</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>10</prism:startingPage>
        <prism:publicationDate>2009-05-29T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cmjournal.org/content/4/1/9">
        <title>Evaluation of Applied Kinesiology meridian techniques by means of surface electromyography (sEMG): demonstration of the regulatory influence of antique acupuncture points</title>
        <description>Background:
The use of Applied Kinesiology techniques based on manual muscle tests relies on the relationship between muscles and acupuncture meridians. Applied Kinesiology detects body dysfunctions based on changes in muscle tone. Muscle tonification or inhibition within the test setting can be achieved with selected acupoints. These acupoints belong to either the same meridian or related meridians. The aim of this study is to analyze muscle sedation and tonification by means of surface electromyography.
Methods:
Manual muscle tests were carried out using standard Applied Kinesiology (AK) techniques. The investigation included basic AK procedures such as sedation and tonification with specific acupoints. The sedation and tonification acupoints were selected from related meridians according to the Five Elements. The tonification effect of these acupoints was also tested while interfering effects were induced by manual stimulation of scars. The effects of selective neural therapy, i.e. individually tested and selected anesthetic agent, for the treatment of scars were also studied. The characteristics of muscle action were documented by surface electromyographys (sEMG).
Results:
The sEMG data showed a diminution of signal intensity when sedation was used. Graded sedation resulted in a graded diminution of signal amplitude. Graded increase in signal amplitude was observed when antique acupuncture points were used for tonification. The tactile stretch stimulus of scars localized in meridian-independent places produced diminution of signal intensity on a reference muscle, similar to sedation. These changes, however, were not corrected by tonification acupoints. Correction of these interferences was achieved by lesion specific neural therapy with local anesthetics.
Conclusion:
We demonstrated the central working principles, i.e. sedation and tonification, of Applied Kinesiology through the use of specific acupoints that have an influence on manual muscle tests. Sedation decreases RMS signal in sEMG, whereas tonification increases it. Interfering stimuli from scars were corrected by selective neural therapy.</description>
        <link>http://www.cmjournal.org/content/4/1/9</link>
                <dc:creator>Roy Moncayo</dc:creator>
                <dc:creator>Helga Moncayo</dc:creator>
                <dc:source>Chinese Medicine 2009, 4:9</dc:source>
        <dc:date>2009-05-29T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8546-4-9</dc:identifier>
        <prism:publicationName>Chinese Medicine</prism:publicationName>
        <prism:issn>1749-8546</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>9</prism:startingPage>
        <prism:publicationDate>2009-05-29T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cmjournal.org/content/4/1/8">
        <title>Further validation of the Health Scale of Traditional Chinese Medicine (HSTCM)</title>
        <description>Background:
Few health measurement scales are based on Chinese medicine theory. The Health Scale of Traditional Chinese Medicine (HSTCM) was developed to fill this gap. The aim of this study is to validate the HSTCM.
Methods:
A convenience sample of 630 participants was recruited in 11 settings. All participants were asked to complete the HSTCM and World Health Organization Quality of Life Measure-Abbreviated Version (WHOQOL-BREF).
Results:
Properties of the HSTCM were tested. Intra-class correlation coefficient representing the inter-interviewer reliability was 0.99 (95%CI) for the overall instrument. Spearman-Brown correlation coefficient and Cronbach&apos;s coefficient alpha were 0.81 and 0.94 respectively, indicating satisfactory internal reliability and inter-interviewer reliability. Spearman&apos;s rho correlation coefficient between the HSTCM and WHOQOL-BREFF was -0.67. A receiver operating characteristic (ROC) curve analysis was performed to test the discriminate validation. Areas under the ROC curve analysis for the HSTCM and its domains ranged 0.71&#8211;0.87 and all the lower levels of 95%CI were greater than 0.50.
Conclusion:
The HSTCM was validated as a generic health scale and may complement existing health measurement scales in Chinese medicine health care.</description>
        <link>http://www.cmjournal.org/content/4/1/8</link>
                <dc:creator>Darong Wu</dc:creator>
                <dc:creator>Shilong Lai</dc:creator>
                <dc:creator>Luojing Zhou</dc:creator>
                <dc:creator>Xinfeng Guo</dc:creator>
                <dc:creator>Weixiong Liang</dc:creator>
                <dc:creator>Zehuai Wen</dc:creator>
                <dc:creator>Aihua Ou</dc:creator>
                <dc:creator>Guangqing Zhang</dc:creator>
                <dc:creator>Keji Chen</dc:creator>
                <dc:source>Chinese Medicine 2009, 4:8</dc:source>
        <dc:date>2009-04-30T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8546-4-8</dc:identifier>
        <prism:publicationName>Chinese Medicine</prism:publicationName>
        <prism:issn>1749-8546</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>8</prism:startingPage>
        <prism:publicationDate>2009-04-30T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cmjournal.org/content/4/1/7">
        <title>Recent developments of acupuncture in Australia and the way forward</title>
        <description>Almost one in ten Australians has received acupuncture treatment by acupuncturists and/or medical doctors in private clinics. The majority of Australian health insurance funds offer rebates for acupuncture. Statutory regulations for acupuncture have been implemented in the State of Victoria, Australia. Six acupuncture degree courses have been approved by the Chinese Medicine Registration Board of Victoria and/or accredited by the Australian Acupuncture and Chinese Medicine Association. Furthermore, a number of clinical trials of acupuncture on allergic rhinitis, pain and women&apos;s health were carried out in Australia. Recent developments of acupuncture in Australia indicate that through adequate and appropriate evaluation, acupuncture begins to integrate into mainstream health care in Australia.</description>
        <link>http://www.cmjournal.org/content/4/1/7</link>
                <dc:creator>Charlie Xue</dc:creator>
                <dc:creator>Anthony Zhang</dc:creator>
                <dc:creator>Angela Yang</dc:creator>
                <dc:creator>Shuiqing Zhang</dc:creator>
                <dc:creator>David Story</dc:creator>
                <dc:source>Chinese Medicine 2009, 4:7</dc:source>
        <dc:date>2009-04-29T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8546-4-7</dc:identifier>
        <prism:publicationName>Chinese Medicine</prism:publicationName>
        <prism:issn>1749-8546</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>7</prism:startingPage>
        <prism:publicationDate>2009-04-29T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cmjournal.org/content/4/1/6">
        <title>Effects of Astragaloside IV on heart failure in rats</title>
        <description>Background:
Astragaloside IV (ASI) in Radix Astragali is believed to be the active component in treating heart failure. The present study aims to examine the effects of ASI on cardiovascular parameters in long-term heart failure in rats.
Methods:
Using echocardiographic and haemodynamic measurements, we studied the effects of ASI on congestive heart failure (CHF) induced by ligation of the left coronary artery in rats.
Results:
ASI (0.1, 0.3 and 1.0 mg/kg/day) attenuated the decline of fractional shortening (FS). The peak derivatives of the left ventricle (LV) pressure (dp/dt) in ASI-treated groups significantly increased. Both LV internal diameters in diastole (LVIDd) and in systole (LVIDs) decreased significantly after ASI treatment (0.3 and 1.0 mg/kg/day). ASI (1.0 mg/kg/day) attenuated the decrease of LV systolic pressure (LVSP). ASI treatment inhibited compensatory hypertrophy of myocardial cells and lowered the number of apoptotic myocytes.
Conclusion:
ASI improved cardiac functions as measured by cardiovascular parameters.</description>
        <link>http://www.cmjournal.org/content/4/1/6</link>
                <dc:creator>Zhuanyou Zhao</dc:creator>
                <dc:creator>Weiting Wang</dc:creator>
                <dc:creator>Fang Wang</dc:creator>
                <dc:creator>Kerui Zhao</dc:creator>
                <dc:creator>Yingmei Han</dc:creator>
                <dc:creator>Weiren Xu</dc:creator>
                <dc:creator>Lida Tang</dc:creator>
                <dc:source>Chinese Medicine 2009, 4:6</dc:source>
        <dc:date>2009-04-02T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8546-4-6</dc:identifier>
        <prism:publicationName>Chinese Medicine</prism:publicationName>
        <prism:issn>1749-8546</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>6</prism:startingPage>
        <prism:publicationDate>2009-04-02T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cmjournal.org/content/4/1/5">
        <title>Stimulation of Apolipoprotein A-IV expression in Caco-2/TC7 enterocytes and reduction of triglyceride formation in 3T3-L1 adipocytes by potential anti-obesity Chinese herbal medicines</title>
        <description>Background:
Chinese medicine has been proposed as a novel strategy for the prevention of metabolic disorders such as obesity. The present study tested 17 Chinese medicinal herbs were tested for their potential anti-obesity effects.
Methods:
The herbs were evaluated in terms of their abilities to stimulate the transcription of Apolipoprotein A-IV (ApoA-IV) in cultured Caco-2/TC7 enterocytes. The herbs that showed stimulating effects on ApoA-IV transcription were further evaluated in terms of their abilities to reduce the formation of triglyceride in differentiated 3T3-L1 adipocytes.
Results:
ApoA-IV transcription was stimulated by Rhizoma Alismatis and Radix Angelica Sinensis in a dose- and time-dependent manner in cultured Caco-2/TC7 cells. Moreover, these two herbs reduced the amount of triglyceride in differentiated 3T3-L1 adipocytes.
Conclusion:
The results suggest that Rhizoma Alistmatis and Radix Angelica Sinensis may have potential anti-obesity effects as they stimulate ApoA-IV transcription and reduce triglyceride formation.</description>
        <link>http://www.cmjournal.org/content/4/1/5</link>
                <dc:creator>Ava Jiangyang Guo</dc:creator>
                <dc:creator>Roy Chi-yan Choi</dc:creator>
                <dc:creator>Anna Wing-han Cheung</dc:creator>
                <dc:creator>Jun Li</dc:creator>
                <dc:creator>Ivy Xiaoying Chen</dc:creator>
                <dc:creator>Tina Tingxia Dong</dc:creator>
                <dc:creator>Karl Wah-keung Tsim</dc:creator>
                <dc:creator>Brad Wing-chuen Lau</dc:creator>
                <dc:source>Chinese Medicine 2009, 4:5</dc:source>
        <dc:date>2009-03-26T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8546-4-5</dc:identifier>
        <prism:publicationName>Chinese Medicine</prism:publicationName>
        <prism:issn>1749-8546</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>5</prism:startingPage>
        <prism:publicationDate>2009-03-26T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cmjournal.org/content/4/1/4">
        <title>Moxibustion and other acupuncture point stimulation methods to treat breech presentation: a systematic review of clinical trials</title>
        <description>Background:
Moxibustion, acupuncture and other acupoint stimulations are commonly used for the correction of breech presentation. This systematic review aims to evaluate the efficacy and safety of moxibustion and other acupoint stimulations to treat breech presentation.
Methods:
We included randomized controlled trials (RCTs) and controlled clinical trials (CCTs) on moxibustion, acupuncture or any other acupoint stimulating methods for breech presentation in pregnant women. All searches in PubMed, the Cochrane Library (2008 Issue 2), China National Knowledge Information (CNKI), Chinese Scientific Journal Database (VIP) and WanFang Database ended in July 2008. Two authors extracted and analyzed the data independently.
Results:
Ten RCTs involving 2090 participants and seven CCTs involving 1409 participants were included in the present study. Meta-analysis showed significant differences between moxibustion and no treatment (RR 1.35, 95% CI 1.20 to 1.51; 3 RCTs). Comparison between moxibustion and knee-chest position did not show significant differences (RR 1.30, 95% CI 0.95 to 1.79; 3 RCTs). Moxibustion plus other therapeutic methods showed significant beneficial effects (RR 1.36, 95% CI 1.21 to 1.54; 2 RCTs). Laser stimulation was more effective than assuming the knee-chest position plus pelvis rotating. Moxibustion was more effective than no treatment (RR 1.29, 95% CI 1.17 to 1.42; 2 CCTs) but was not more effective than the knee-chest position treatment (RR 1.22, 95% CI 1.11 to 1.34; 2 CCTs). Laser stimulation at Zhiyin (BL67) was more effective than the knee-chest position treatment (RR 1.30, 95% CI 1.10 to 1.54; 2 CCTs,).
Conclusion:
Moxibustion, acupuncture and laser acupoint stimulation tend to be effective in the correction of breech presentation.</description>
        <link>http://www.cmjournal.org/content/4/1/4</link>
                <dc:creator>Xun Li</dc:creator>
                <dc:creator>Jun Hu</dc:creator>
                <dc:creator>Xiaoyi Wang</dc:creator>
                <dc:creator>Huiri Zhang</dc:creator>
                <dc:creator>Jianping Liu</dc:creator>
                <dc:source>Chinese Medicine 2009, 4:4</dc:source>
        <dc:date>2009-02-27T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8546-4-4</dc:identifier>
        <prism:publicationName>Chinese Medicine</prism:publicationName>
        <prism:issn>1749-8546</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>4</prism:startingPage>
        <prism:publicationDate>2009-02-27T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
